Brief: Paion Announces Approval Of Compassionate Use For Remimazolam
June 2 (Reuters) - PAION AG PA8G.DE :
* PAION ANNOUNCES APPROVAL OF COMPASSIONATE USE FOR
REMIMAZOLAM IN
ITALIAN HOSPITAL
* APPROVAL FOR COMPASSIONATE USE OF REMIMAZOLAM FOR USE OF
SEDATION OF FIVE INTENSIVE CARE UNIT (ICU) PATIENTS WITH
COVID-19
Source text for Eikon: ID:nEQ7KsgyWa
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022